First Oral Treatment for Relapsed, Refractory Acute Myeloid Leukemia Wins FDA Approval
August 1st 2017Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) to treat adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release.
Read More
How a Bucket of Chicken Can Help You Achieve Any Goal You Have (Part 1)
August 1st 2017The next time you see a bucket of chicken, I hope you reminds you my absolute favorite pneumonic device and how you can begin to work towards any goal you set out to achieve. Fortunately, this acronym is easy to remember and seen all over the world with signs of a global food franchise: Kentucky Fried Chicken, otherwise known as KFC.
Read More